Interestingly, since the presence of BRCA1/2 mutations is the major cause of HRD, they used their ML model to predict the HRD status of 124 ovarian or breast cancers without mutations in any of the HR genes and 114 cancers with mutations in one of the genes involved in HR. This evidence concerns the gene BRCA1 and cancer.